1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research & Forecasting

2.1. Research Methodology
2.1.1. Research Process
2.1.2. Research Framework
2.1.3. Research Reliability & Validity
2.1.4. Research Assumptions
2.2. Forecasting Methodology

3. Executive Summary

3.1. Market Outlook
3.1.1. The regulations on the use of cannabis or cannabis products have controlled the social impact in recent years and limited the use of cannabis for the medicinal and recreational purpose
3.1.2. The CBD Hemp oil applications are no longer limited to health or medical benefit, the players or providers have shown a shift towards offering the products for infused foods and beverages, pet care, and cosmetic applications
3.1.3. The international law and policies regulating the trade of CBD products are including the stringent terms & conditions related to processing, distributing, selling, and the usage specific to each CBD product.
3.1.4. The Americas represents a dominant share of the overall market in 2018
3.1.5. Shareholders approve planned cannabis merger of Canopy Growth and Acreage
3.2. Market Data Feed

4. Premium Insight

4.1. Market Connectivity
4.2. Market Dynamics
4.2.1. Drivers
4.2.1.1. Increased social acceptance of cannabis and cannabis infused products globally
4.2.1.2. Increasing use in treatment of the patients diagnosed with neurological disorders and other chronic diseases
4.2.1.3. Legalised supply of quality-controlled CBD oil for sale
4.2.1.4. Increasing demand of cannabis-infused foods and beverages
4.2.1.5. Legalized production of cannabis in North America
4.2.1.6. Import and export of cannabis or cannabis products for medical and scientific purposes
4.2.1.7. In-house cultivation cannabis
4.2.2. Restraints
4.2.2.1. Poor guidance and inaccurate dosing resulting in dangerous consequences
4.2.2.2. Product developers need to be constantly on their toes
4.2.2.3. Use, distribution, possessing, and selling cannabis oil subject to varying international laws
4.2.3. Opportunities
4.2.3.1. New product development related to cannabis-infused foods and beverages
4.2.3.2. Pharmaceutical companies and beverage companies eyeing the cannabis industry
4.2.4. Challenges
4.2.4.1. Heavy taxes imposed on cannabis industry discourages commercialaization
4.3. Porters Five Forces Analysis
4.3.1. Threat of New Entrants
4.3.2. Threat of Substitutes
4.3.3. Bargaining Power of Customers
4.3.4. Bargaining Power of Suppliers
4.3.5. Industry Rivalry
4.4. Client Customizations
4.4.1. Legislative and Regulatory Framework
4.4.2. Epidemiological data for cannabis use and dependence

5. Global Cannabinoid Hemp Oil Market, by Form

5.1. Overview
5.2. Market Sizing & Forecasting
5.3. Concentrated Oil
5.4. Cream
5.5. Food Additive
5.6. Inhaled Liquids
5.7. Supplement Capsule
5.8. Tincture Spray

6. Global Cannabinoid Hemp Oil Market, by Source

6.1. Overview
6.2. Market Sizing & Forecasting
6.3. Inorganic
6.4. Organic

7. Global Cannabinoid Hemp Oil Market, by Distribution Mode

7.1. Overview
7.2. Market Sizing & Forecasting
7.3. Offline Mode
7.4. Online Mode

8. Global Cannabinoid Hemp Oil Market, by Application

8.1. Overview
8.2. Market Sizing & Forecasting
8.3. Cosmetics & Personal Care
8.4. Food & Beverage
8.5. Medical & Pharmaceuticals
8.6. Pet Care

9. Global Cannabinoid Hemp Oil Market, by Geography

9.1. Overview
9.2. Market Sizing & Forecasting
9.3. Americas
9.3.1. Argentina
9.3.2. Brazil
9.3.3. Canada
9.3.4. Chile
9.3.5. Mexico
9.3.6. United States
9.4. Asia-Pacific
9.4.1. Australia
9.4.2. China
9.4.3. India
9.4.4. Indonesia
9.4.5. Japan
9.4.6. Malaysia
9.4.7. Philippines
9.4.8. South Korea
9.4.9. Thailand
9.5. Europe, Middle East & Africa
9.5.1. Denmark
9.5.2. France
9.5.3. Germany
9.5.4. Italy
9.5.5. Netherlands
9.5.6. Qatar
9.5.7. Russia
9.5.8. Saudi Arabia
9.5.9. South Africa
9.5.10. Spain
9.5.11. United Arab Emirates
9.5.12. United Kingdom
10. Competitive Landscape
10.1. FPNV Positioning Matrix
10.1.1. Quadrants
10.1.1.1. Forefront
10.1.1.2. Pathfinders
10.1.1.3. Niche
10.1.1.4. Vital
10.1.2. Business Strategy
10.1.2.1. Business Growth
10.1.2.2. Industry Coverage
10.1.2.3. Financial Viability
10.1.2.4. Channel Support
10.1.3. Product Satisfaction
10.1.3.1. Value for Money
10.1.3.2. Ease of Use
10.1.3.3. Product Features
10.1.3.4. Customer Support
10.2. Market Vendor Ranking Analysis
10.3. Competitive News Feed Analysis
11. Company Usability Profiles
11.1. CV Sciences, Inc.
11.1.1. Overview
11.1.2. Strategy
11.1.3. SWOT
11.2. CW Hemp
11.2.1. Overview
11.2.2. Strategy
11.2.3. SWOT
11.3. Canopy Growth Corporation
11.3.1. Overview
11.3.2. Strategy
11.3.3. SWOT
11.4. Isodiol International, Inc.
11.4.1. Overview
11.4.2. Strategy
11.4.3. SWOT
11.5. Medical Marijuana, Inc.
11.5.1. Overview
11.5.2. Strategy
11.5.3. SWOT
11.6. Aphria, Inc.
11.7. CBD Health Solutions, LLC.
11.8. Elixinol LLC
11.9. Endoca
11.10. Folium Biosciences
11.11. Freedom Leaf Inc.
11.12. Green Roads of Florida, LLC
11.13. Kazmira LLC
11.14. NuLeaf Naturals LLC
11.15. Pharmahemp
12. Appendix
12.1. Discussion Guide
12.2. Author Details

Companies Mentioned

1. Canopy Growth Corporation
2. CV Sciences, Inc.
3. CW Hemp
4. Isodiol International, Inc.
5. Medical Marijuana, Inc.
6. Aphria, Inc.
7. CBD Health Solutions, LLC.
8. Elixinol LLC
9. Endoca
10. Folium Biosciences
11. Freedom Leaf Inc.
12. Green Roads of Florida, LLC
13. Kazmira LLC
14. NuLeaf Naturals LLC
15. Pharmahemp